nodes	percent_of_prediction	percent_of_DWPC	metapath
Levomethadyl Acetate—CYP19A1—Betamethasone—multiple sclerosis	0.257	0.285	CbGbCtD
Levomethadyl Acetate—CYP19A1—Dexamethasone—multiple sclerosis	0.149	0.166	CbGbCtD
Levomethadyl Acetate—CYP3A4—Fingolimod—multiple sclerosis	0.0776	0.0863	CbGbCtD
Levomethadyl Acetate—CYP3A7—Dexamethasone—multiple sclerosis	0.0646	0.0719	CbGbCtD
Levomethadyl Acetate—CYP3A7-CYP3A51P—Dexamethasone—multiple sclerosis	0.0646	0.0719	CbGbCtD
Levomethadyl Acetate—CYP3A4—Methylprednisolone—multiple sclerosis	0.05	0.0556	CbGbCtD
Levomethadyl Acetate—CYP3A5—Dexamethasone—multiple sclerosis	0.0485	0.0539	CbGbCtD
Levomethadyl Acetate—CYP3A4—Triamcinolone—multiple sclerosis	0.0379	0.0421	CbGbCtD
Levomethadyl Acetate—CYP3A4—Mitoxantrone—multiple sclerosis	0.0365	0.0406	CbGbCtD
Levomethadyl Acetate—CYP3A4—Betamethasone—multiple sclerosis	0.0325	0.0361	CbGbCtD
Levomethadyl Acetate—CYP3A4—Prednisolone—multiple sclerosis	0.0321	0.0357	CbGbCtD
Levomethadyl Acetate—CYP3A4—Prednisone—multiple sclerosis	0.0303	0.0337	CbGbCtD
Levomethadyl Acetate—CYP3A4—Dexamethasone—multiple sclerosis	0.0189	0.021	CbGbCtD
Levomethadyl Acetate—OPRM1—nerve—multiple sclerosis	0.00218	0.144	CbGeAlD
Levomethadyl Acetate—CHRNA3—retina—multiple sclerosis	0.00148	0.0978	CbGeAlD
Levomethadyl Acetate—CHRNB4—nervous system—multiple sclerosis	0.00131	0.0865	CbGeAlD
Levomethadyl Acetate—Loperamide—POMC—multiple sclerosis	0.0013	1	CrCbGaD
Levomethadyl Acetate—CHRNB4—central nervous system—multiple sclerosis	0.00126	0.0833	CbGeAlD
Levomethadyl Acetate—CHRNB4—brain—multiple sclerosis	0.001	0.0661	CbGeAlD
Levomethadyl Acetate—OPRM1—brainstem—multiple sclerosis	0.000934	0.0617	CbGeAlD
Levomethadyl Acetate—CHRNA3—nervous system—multiple sclerosis	0.000803	0.0531	CbGeAlD
Levomethadyl Acetate—CYP19A1—Ovarian Infertility Genes—VDR—multiple sclerosis	0.000778	0.00922	CbGpPWpGaD
Levomethadyl Acetate—CHRNA3—central nervous system—multiple sclerosis	0.000774	0.0511	CbGeAlD
Levomethadyl Acetate—OPRM1—TCR Signaling Pathway—CBLB—multiple sclerosis	0.00077	0.00913	CbGpPWpGaD
Levomethadyl Acetate—CHRNA3—cerebellum—multiple sclerosis	0.000756	0.05	CbGeAlD
Levomethadyl Acetate—CYP3A5—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000731	0.00867	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000731	0.00867	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Endogenous sterols—POMC—multiple sclerosis	0.000696	0.00825	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000661	0.00783	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000661	0.00783	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Biological oxidations—CYP24A1—multiple sclerosis	0.000619	0.00734	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Biological oxidations—CYP27B1—multiple sclerosis	0.000619	0.00734	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—G-protein activation—POMC—multiple sclerosis	0.000618	0.00733	CbGpPWpGaD
Levomethadyl Acetate—CHRNA3—brain—multiple sclerosis	0.000614	0.0406	CbGeAlD
Levomethadyl Acetate—CYP19A1—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.00061	0.00724	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.00061	0.00724	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—TCR Signaling Pathway—MALT1—multiple sclerosis	0.000603	0.00714	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—midbrain—multiple sclerosis	0.000595	0.0393	CbGeAlD
Levomethadyl Acetate—CYP3A4—Irinotecan Pathway—BCHE—multiple sclerosis	0.000585	0.00693	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Integrated Breast Cancer Pathway—ZMIZ1—multiple sclerosis	0.000584	0.00692	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—spinal cord—multiple sclerosis	0.000581	0.0384	CbGeAlD
Levomethadyl Acetate—OPRM1—Peptide GPCRs—CXCR3—multiple sclerosis	0.000563	0.00668	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Peptide GPCRs—CCR2—multiple sclerosis	0.000548	0.0065	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Biological oxidations—CYP24A1—multiple sclerosis	0.000537	0.00637	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Biological oxidations—CYP27B1—multiple sclerosis	0.000537	0.00637	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.00053	0.00628	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.00053	0.00628	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of steroid hormones and vitamin D—POMC—multiple sclerosis	0.000522	0.00618	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000515	0.0061	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—TCR Signaling Pathway—IL17A—multiple sclerosis	0.000491	0.00582	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—nervous system—multiple sclerosis	0.000489	0.0323	CbGeAlD
Levomethadyl Acetate—CHRNB4—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	0.000481	0.0057	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—TCR Signaling Pathway—CD28—multiple sclerosis	0.000477	0.00566	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—central nervous system—multiple sclerosis	0.000471	0.0311	CbGeAlD
Levomethadyl Acetate—CHRNA3—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000471	0.00558	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—SIDS Susceptibility Pathways—IL10—multiple sclerosis	0.000459	0.00544	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—G alpha (i) signalling events—S1PR1—multiple sclerosis	0.000458	0.00543	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—IL4-mediated signaling events—CD40LG—multiple sclerosis	0.00045	0.00533	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—IL4-mediated signaling events—IL10—multiple sclerosis	0.00045	0.00533	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—IL4-mediated signaling events—IL4—multiple sclerosis	0.000438	0.00519	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000419	0.00497	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000419	0.00497	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000414	0.00491	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000414	0.00491	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—nervous system—multiple sclerosis	0.000411	0.0272	CbGeAlD
Levomethadyl Acetate—OPRM1—Peptide ligand-binding receptors—CCR1—multiple sclerosis	0.0004	0.00474	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Peptide ligand-binding receptors—CXCL13—multiple sclerosis	0.0004	0.00474	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—central nervous system—multiple sclerosis	0.000396	0.0262	CbGeAlD
Levomethadyl Acetate—CHRNB4—Neuronal System—BCHE—multiple sclerosis	0.000394	0.00468	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—G alpha (i) signalling events—RGS1—multiple sclerosis	0.000389	0.00461	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Biological oxidations—CYP27B1—multiple sclerosis	0.000389	0.00461	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Biological oxidations—CYP24A1—multiple sclerosis	0.000389	0.00461	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000383	0.00454	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000383	0.00454	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000376	0.00446	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—brain—multiple sclerosis	0.000374	0.0247	CbGeAlD
Levomethadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—S1PR1—multiple sclerosis	0.000364	0.00431	CbGpPWpGaD
Levomethadyl Acetate—CHRNA3—Neuronal System—BCHE—multiple sclerosis	0.000361	0.00428	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Peptide GPCRs—CCR5—multiple sclerosis	0.000353	0.00419	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—FSH signaling pathway—MAPK1—multiple sclerosis	0.000346	0.00411	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCRs, Class A Rhodopsin-like—GPR65—multiple sclerosis	0.000342	0.00406	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.00034	0.00403	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.00034	0.00403	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—G alpha (i) signalling events—CCR1—multiple sclerosis	0.000337	0.004	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—G alpha (i) signalling events—CXCL13—multiple sclerosis	0.000337	0.004	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—TCR Signaling Pathway—CD8A—multiple sclerosis	0.00033	0.00391	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000323	0.00383	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—brain—multiple sclerosis	0.000314	0.0208	CbGeAlD
Levomethadyl Acetate—OPRM1—GPCRs, Class A Rhodopsin-like—CCR1—multiple sclerosis	0.000313	0.00371	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—TCR Signaling Pathway—CCR5—multiple sclerosis	0.000302	0.00358	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—TCR Signaling Pathway—FAS—multiple sclerosis	0.000299	0.00355	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—GPR65—multiple sclerosis	0.000293	0.00348	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Peptide ligand-binding receptors—CCL3—multiple sclerosis	0.000285	0.00338	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000281	0.00333	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR ligand binding—S1PR1—multiple sclerosis	0.000277	0.00329	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL13—multiple sclerosis	0.000268	0.00318	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR1—multiple sclerosis	0.000268	0.00318	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Peptide ligand-binding receptors—CXCR3—multiple sclerosis	0.000265	0.00314	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000262	0.00311	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Peptide ligand-binding receptors—CCR2—multiple sclerosis	0.000258	0.00306	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Opioid Signalling—POMC—multiple sclerosis	0.000257	0.00304	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	0.000241	0.00286	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000238	0.00282	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000238	0.00282	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000228	0.0027	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—G alpha (i) signalling events—CXCR3—multiple sclerosis	0.000224	0.00265	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR ligand binding—GPR65—multiple sclerosis	0.000223	0.00265	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—G alpha (i) signalling events—CCR2—multiple sclerosis	0.000217	0.00258	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000216	0.00256	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCRs, Class A Rhodopsin-like—PTGER4—multiple sclerosis	0.000215	0.00255	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Peptide ligand-binding receptors—CXCL10—multiple sclerosis	0.000214	0.00254	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCRs, Class A Rhodopsin-like—CXCR3—multiple sclerosis	0.000207	0.00246	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR ligand binding—CCR1—multiple sclerosis	0.000204	0.00242	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR ligand binding—CXCL13—multiple sclerosis	0.000204	0.00242	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000203	0.00241	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCRs, Class A Rhodopsin-like—CCR2—multiple sclerosis	0.000202	0.00239	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—G alpha (i) signalling events—CNR1—multiple sclerosis	0.000201	0.00238	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	0.0002	0.00237	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—nervous system—multiple sclerosis	0.000199	0.0132	CbGeAlD
Levomethadyl Acetate—CYP3A4—central nervous system—multiple sclerosis	0.000192	0.0127	CbGeAlD
Levomethadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL3—multiple sclerosis	0.000191	0.00227	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—TCR Signaling Pathway—CD4—multiple sclerosis	0.00019	0.00225	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCRs, Class A Rhodopsin-like—CNR1—multiple sclerosis	0.000186	0.00221	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Peptide ligand-binding receptors—CCL5—multiple sclerosis	0.000184	0.00219	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—PTGER4—multiple sclerosis	0.000184	0.00218	CbGpPWpGaD
Levomethadyl Acetate—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	0.000183	0.00217	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—G alpha (i) signalling events—CXCL10—multiple sclerosis	0.000181	0.00214	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	0.000181	0.00214	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	0.000181	0.00214	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000178	0.00211	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000178	0.00211	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	0.000178	0.00211	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—TCR Signaling Pathway—IL1B—multiple sclerosis	0.000175	0.00208	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—SIDS Susceptibility Pathways—TNF—multiple sclerosis	0.000175	0.00207	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	0.000173	0.00205	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Peptide ligand-binding receptors—CCR5—multiple sclerosis	0.000166	0.00197	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000165	0.00195	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	0.00016	0.00189	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—S1PR1—multiple sclerosis	0.000157	0.00186	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—G alpha (i) signalling events—CCL5—multiple sclerosis	0.000156	0.00184	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	0.00015	0.00178	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—SRM—multiple sclerosis	0.00015	0.00178	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR ligand binding—CCL3—multiple sclerosis	0.000146	0.00173	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Opioid Signalling—MAPK1—multiple sclerosis	0.000145	0.00172	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	0.000144	0.0017	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—S1PR1—multiple sclerosis	0.000142	0.00169	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—SIDS Susceptibility Pathways—IL6—multiple sclerosis	0.000141	0.00167	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR ligand binding—PTGER4—multiple sclerosis	0.00014	0.00166	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—G alpha (i) signalling events—CCR5—multiple sclerosis	0.00014	0.00166	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Biological oxidations—POMC—multiple sclerosis	0.000139	0.00165	CbGpPWpGaD
Levomethadyl Acetate—CHRNA3—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	0.000138	0.00163	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—TCR Signaling Pathway—TGFB1—multiple sclerosis	0.000136	0.00161	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR ligand binding—CXCR3—multiple sclerosis	0.000135	0.0016	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—TCR Signaling Pathway—MAPK1—multiple sclerosis	0.000133	0.00158	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—RGS1—multiple sclerosis	0.000133	0.00158	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR ligand binding—CCR2—multiple sclerosis	0.000132	0.00156	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—SRM—multiple sclerosis	0.00013	0.00155	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.00013	0.00154	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Peptide ligand-binding receptors—POMC—multiple sclerosis	0.00013	0.00154	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Peptide ligand-binding receptors—CCL2—multiple sclerosis	0.000127	0.00151	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—GPR65—multiple sclerosis	0.000126	0.0015	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.000124	0.00147	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR ligand binding—CNR1—multiple sclerosis	0.000122	0.00144	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—RGS1—multiple sclerosis	0.000121	0.00143	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Biological oxidations—POMC—multiple sclerosis	0.000121	0.00143	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—CCR1—multiple sclerosis	0.000115	0.00137	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000115	0.00137	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—Neuronal System—MAPK1—multiple sclerosis	0.000115	0.00137	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—GPR65—multiple sclerosis	0.000115	0.00136	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.000111	0.00132	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—LINGO1—multiple sclerosis	0.000111	0.00131	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—G alpha (i) signalling events—POMC—multiple sclerosis	0.00011	0.0013	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR ligand binding—CXCL10—multiple sclerosis	0.000109	0.0013	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—CYP27B1—multiple sclerosis	0.000106	0.00125	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—CYP24A1—multiple sclerosis	0.000106	0.00125	CbGpPWpGaD
Levomethadyl Acetate—CHRNA3—Neuronal System—MAPK1—multiple sclerosis	0.000105	0.00125	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—CXCL13—multiple sclerosis	0.000105	0.00124	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—CCR1—multiple sclerosis	0.000105	0.00124	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000103	0.00123	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—TCR Signaling Pathway—IL6—multiple sclerosis	0.000103	0.00122	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—GPC5—multiple sclerosis	9.68e-05	0.00115	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—TAGAP—multiple sclerosis	9.61e-05	0.00114	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	9.44e-05	0.00112	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—SRM—multiple sclerosis	9.43e-05	0.00112	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR ligand binding—CCL5—multiple sclerosis	9.42e-05	0.00112	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—CYP27B1—multiple sclerosis	9.19e-05	0.00109	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—CYP24A1—multiple sclerosis	9.19e-05	0.00109	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Integrated Breast Cancer Pathway—MYC—multiple sclerosis	8.93e-05	0.00106	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Biological oxidations—POMC—multiple sclerosis	8.74e-05	0.00104	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Integrated Breast Cancer Pathway—MAPK1—multiple sclerosis	8.74e-05	0.00104	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	8.71e-05	0.00103	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	8.52e-05	0.00101	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR ligand binding—CCR5—multiple sclerosis	8.48e-05	0.00101	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—GPC5—multiple sclerosis	8.41e-05	0.000997	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—S1PR1—multiple sclerosis	8.4e-05	0.000996	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—GPC5—multiple sclerosis	8.17e-05	0.000969	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—RRM1—multiple sclerosis	8.02e-05	0.000951	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—PTGER4—multiple sclerosis	7.92e-05	0.000939	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	7.65e-05	0.000907	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—CXCR3—multiple sclerosis	7.65e-05	0.000907	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—CCL3—multiple sclerosis	7.47e-05	0.000886	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—CCR2—multiple sclerosis	7.44e-05	0.000882	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—PTGER4—multiple sclerosis	7.19e-05	0.000853	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—RGS1—multiple sclerosis	7.14e-05	0.000847	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—RRM1—multiple sclerosis	6.97e-05	0.000826	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—CXCR3—multiple sclerosis	6.95e-05	0.000823	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—CNR1—multiple sclerosis	6.87e-05	0.000814	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—GPR65—multiple sclerosis	6.77e-05	0.000803	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—CCR2—multiple sclerosis	6.76e-05	0.000801	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—CYP27B1—multiple sclerosis	6.64e-05	0.000788	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—CYP24A1—multiple sclerosis	6.64e-05	0.000788	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR ligand binding—POMC—multiple sclerosis	6.63e-05	0.000786	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR ligand binding—CCL2—multiple sclerosis	6.49e-05	0.000769	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—CNR1—multiple sclerosis	6.24e-05	0.000739	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	6.22e-05	0.000738	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—CCR1—multiple sclerosis	6.19e-05	0.000734	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—CXCL13—multiple sclerosis	6.19e-05	0.000734	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—CXCL10—multiple sclerosis	6.18e-05	0.000733	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—GPC5—multiple sclerosis	6.08e-05	0.00072	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—CXCL10—multiple sclerosis	5.61e-05	0.000666	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	5.35e-05	0.000634	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—CCL5—multiple sclerosis	5.32e-05	0.000631	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—RRM1—multiple sclerosis	5.04e-05	0.000597	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	4.87e-05	0.000578	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—CCL5—multiple sclerosis	4.83e-05	0.000573	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—CCR5—multiple sclerosis	4.79e-05	0.000568	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—IL2RA—multiple sclerosis	4.73e-05	0.00056	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—BCHE—multiple sclerosis	4.61e-05	0.000546	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—CCL3—multiple sclerosis	4.41e-05	0.000523	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—SRM—multiple sclerosis	4.38e-05	0.00052	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—CCR5—multiple sclerosis	4.35e-05	0.000516	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—IL2RA—multiple sclerosis	4.29e-05	0.000509	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—PTGER4—multiple sclerosis	4.25e-05	0.000504	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—PGR—multiple sclerosis	4.18e-05	0.000496	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—CXCR3—multiple sclerosis	4.1e-05	0.000486	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—CD28—multiple sclerosis	4.06e-05	0.000482	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Biological oxidations—POMC—multiple sclerosis	4.06e-05	0.000482	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—BCHE—multiple sclerosis	4e-05	0.000474	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—CCR2—multiple sclerosis	3.99e-05	0.000473	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—POMC—multiple sclerosis	3.75e-05	0.000444	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—CNR1—multiple sclerosis	3.68e-05	0.000437	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—POMC—multiple sclerosis	3.4e-05	0.000403	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—CCL2—multiple sclerosis	3.33e-05	0.000395	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—CXCL10—multiple sclerosis	3.32e-05	0.000393	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	3.09e-05	0.000366	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	3.09e-05	0.000366	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—TYK2—multiple sclerosis	3.02e-05	0.000358	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—CD86—multiple sclerosis	2.9e-05	0.000344	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—BCHE—multiple sclerosis	2.89e-05	0.000343	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—CCL5—multiple sclerosis	2.86e-05	0.000338	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—GPC5—multiple sclerosis	2.83e-05	0.000335	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—APOE—multiple sclerosis	2.77e-05	0.000329	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—IL2—multiple sclerosis	2.77e-05	0.000328	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—SPP1—multiple sclerosis	2.64e-05	0.000313	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—CCR5—multiple sclerosis	2.57e-05	0.000305	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—IL2RA—multiple sclerosis	2.54e-05	0.000301	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—IL2—multiple sclerosis	2.52e-05	0.000298	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—APOE—multiple sclerosis	2.41e-05	0.000285	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—POMC—multiple sclerosis	2.38e-05	0.000282	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—RRM1—multiple sclerosis	2.34e-05	0.000278	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—APOE—multiple sclerosis	2.34e-05	0.000277	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—ALB—multiple sclerosis	2.17e-05	0.000257	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—CD80—multiple sclerosis	2.12e-05	0.000251	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—POMC—multiple sclerosis	2.07e-05	0.000245	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—POMC—multiple sclerosis	2.01e-05	0.000238	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—CCL2—multiple sclerosis	1.97e-05	0.000233	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—MAPK1—multiple sclerosis	1.92e-05	0.000228	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—ALB—multiple sclerosis	1.89e-05	0.000223	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—TYK2—multiple sclerosis	1.79e-05	0.000212	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—APOE—multiple sclerosis	1.74e-05	0.000206	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—POMC—multiple sclerosis	1.49e-05	0.000177	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—IL2—multiple sclerosis	1.49e-05	0.000176	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—IL6—multiple sclerosis	1.48e-05	0.000175	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—MMP9—multiple sclerosis	1.41e-05	0.000167	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—ALB—multiple sclerosis	1.36e-05	0.000162	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—BCHE—multiple sclerosis	1.34e-05	0.000159	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—STAT3—multiple sclerosis	1.25e-05	0.000148	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—MYC—multiple sclerosis	1.16e-05	0.000138	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—TGFB1—multiple sclerosis	1.16e-05	0.000137	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—MAPK1—multiple sclerosis	1.14e-05	0.000135	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—IL6—multiple sclerosis	8.74e-06	0.000104	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—APOE—multiple sclerosis	8.09e-06	9.59e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—POMC—multiple sclerosis	6.95e-06	8.24e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—ALB—multiple sclerosis	6.34e-06	7.51e-05	CbGpPWpGaD
